Why pacing of conduction system?

2021 ◽  
Vol 2 (59) ◽  
pp. 4-7
Author(s):  
Przemysław Mitkowski

Cardiac pacing since the 50th of the last century is the standard of care for patients with bradycardia. The aims of this therapy have changed over the decades from a life-saving option to achieve the most physiologic “prosthesis” of the conduction system in patients with atrioventricular blocks and improve depolarization sequence in those with heart failure and intraventricular conduction abnormalities. In the last years, direct conduction system pacing methods are developing very quickly. His bundle pacing, direct left bundle branch pacing with its modifications were introduced into clinical practice. Lack of big, randomized trials and technical aspects of these new modes of pacing caused that these methods haven’t achieved a high class of recommendation in recently published guidelines of the European Society of Cardiology.

2021 ◽  
Vol 2 (59) ◽  
pp. 22-26
Author(s):  
Rafał Gardas ◽  
Krzysztof S. Gołba

Direct conduction system pacing delivers more physiological cardiac activation and can potentially correct intraventricular conduction disturbances and restore normal activation pathways. Permanent pacing that maintains cardiac electromechanical synchrony is essential in heart failure and reduced left ventricular ejection fraction. Conduction system pacing has recently emerged as an alternative to right ventricular pacing and biventricular resynchronization therapy. In this article, we review conduction system pacing in heart failure patients.


2011 ◽  
pp. 5-12
Author(s):  
Anh Tien Hoang ◽  
Van Minh Huynh ◽  
Khanh Hoang ◽  
Huu Dang Tran ◽  
Viet An Tran

NT-ProBNP is a high value cardiac biomarker and widely applies in many cardiovascular diseases. The evaluation of concentration of NT-ProBNP needs the concern about age, gender, obesity and especially we need each cut-off point for each cause of cardiovascular disease in evaluation and clinical application. Because NT-ProBNP is a new cardiac marker and has been researched in 5 recent years, the cut-off of NT-ProBNP is still being studied for the clinical application in cardiovascular diseases. Only the cut-off of NT-ProBNP in diagnosis heart failure was guided by European Society of Cardiology. The meaning of introduce cut-off value of value plays an role as pilot study for the other relate study and brings the NT-ProBNP closely approach to clinical application.


Sign in / Sign up

Export Citation Format

Share Document